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Optimal testing of multiple hypotheses with common effect
direction
Abstract
We present a theoretical basis for testing related endpoints. Typically, it is known how to construct tests
of the individual hypotheses, and the problem is how to combine them into a multiple test procedure that
controls the familywise error rate. Using the closure method, we emphasize the role of consonant
procedures, from an interpretive as well as a theoretical viewpoint, and introduce a new procedure,
which is consonant and has a maximin property under the normal model. The results are then applied to
PROactive, a clinical trial designed to investigate the effectiveness of a glucose-lowering drug on
macrovascular outcomes among patients with type 2 diabetes.
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Summary. We present a theoretical basis for testing related endpoints. Typically, it is known
how to construct tests of the individual hypotheses, and the problem is how to combine them
into a multiple test procedure that controls the familywise error rate. Using the closure method,
we emphasize the role of consonant procedures, from an interpretive as well as a theoretical
viewpoint, and introduce a new procedure, which is consonant and has a maximin property
under the normal model. The results are then applied to PROactive, a clinical trial designed
to investigate the effectiveness of a glucose-lowering drug on macrovascular outcomes among
patients with type 2 diabetes.
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1 Introduction
In research and experimentation it is common to specify several hypotheses. In clinical research,
these have been characterized as primary (usually one hypothesis or “endpoint”) and secondary
(one or more endpoints to be tested if the primary endpoint is significant). More frequently
now, clinical trials feature multiple, co-primary endpoints, the significance of any of which
forms the basis for a claim of efficacy. Therefore, for both scientific and regulatory reasons,
the familywise error rate (FWE) for the family of co-primary endpoints is to be controlled.
Further, it may be reasonable to expect that every co-primary endpoint will exhibit an effect of
treatment, possibly some to a greater degree than others. This is the common effect direction
alluded to in the title.
The desire to focus power on a common direction led O’Brien (1984) to combine multiple
test statistics into a single hypothesis test. Under a normal model assumption, O’Brien derived
an ordinary least squares (OLS) test statistic and a generalized least squares (GLS) test statistic
that are more powerful than Hotelling’s T 2 statistic in the case of related endpoints. Lehmacher
et al. (1991) apply O’Brien’s test in combination with the closure principle of Marcus et.al.
(1976). Lehmacher et al. point out that the Bonferroni test—and by extension, stepdown
tests based on the maximum test statistic (for example, Romano and Wolf, 2005)— is useful
for detecting one highly significant difference, or treatment effect, among a group of otherwise
barely or non-significant differences; while O’Brien’s tests, based on the unweighted or weighted
sum of test statistics, succeed in rejecting the global null against alternatives closer to the
diagonal, meaning a group of similar treatment effects. Pocock et al. (1987) extend this
approach to a general situation of asymptotically normal test statistics. Summing test statistics
in the multivariate survival analysis setting, as we do in the example later, became theoretically
justified with the WLW method, due to Wei et al. (1989). The main problem we consider is
how to combine tests of individual hypotheses into a multiple testing procedure that is sensitive
or powerful when the endpoints are related.
Data X is available, whose distribution is given by a model P = {Pθ, θ ∈ Ω}. The
parameter space Ω can be parametric, semiparametric or nonparametric, since θ merely indexes
the parameter space. In order to devise a procedure which controls the FWE, the closure
method reduces the problem to constructing tests that control the usual probability of Type
1 error. Specifically, for a subset K ⊆ {1, . . . , s} and ωi ⊂ Ω, let HK denote the intersection
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hypothesis defined by
HK = ωK ≡
⋂
i∈K
ωi ; (1)
that is, HK is true if and only if θ ∈
⋂
i∈K ωi. Of course, Hi = H{i}. Suppose φK is an α level
test of HK , that is, supθ∈ωK Eθ[φK(X)] ≤ α. Then, the decision rule that rejects Hi if HK is
rejected for all subsets K for which {i} ⊆ K strongly controls the FWE.
Consider the choice of tests of HK . Even in the case s = 2, little formal theory exists in the
design of tests of HK . However, many ad hoc procedures have been developed; see Hochberg
and Tamhane (1987), Westfall and Young (1993), Romano and Wolf (2005), and the references
therein. These approaches incorporate the dependence structure of the data and improve on
Holm’s (1979) method.
Stepdown tests based on the maximum test statistic yield multiple test procedures which
satisfy a property called consonance; for a discussion of such tests see Remark 3.1 or Romano
and Wolf (2005). A testing method is consonant when the rejection of an intersection hypoth-
esis implies the rejection of at least one of its component hypotheses. An associated concept
is that of coherence, which states that the non-rejection of an intersection hypothesis implies
the non-rejection of any subset hypothesis it implies. Coherence is de facto true in any closed
testing method. Consider a randomized experiment for testing the efficacy of a drug versus a
placebo with two primary endpoints in a closed test setting: testing for reduction in headaches
(H1) and testing for reduction in muscle pain (H2). If the joint intersection hypothesis H{1,2}
is rejected, but neither individual hypothesis is rejected, then one might conclude that the
drug has some beneficial effect, but compelling evidence has not been established to promote
a particular drug indication. Lack of consonance, which is alternatively called dissonance,
makes interpretation awkward. Moreover, we will argue that, in the framework we are con-
cerned with here, dissonance is undesirable in that it results in decreased ability to reject false
null hypotheses.
Sonnemann and Finner (1988) showed that any incoherent procedure can be replaced by
a coherent one which is at least as good. Sonnemann (1982) also showed that all coherent
procedures which control the FWE must be obtained by the closure method. Therefore, our
restriction to procedures based on the closure method is no restriction at all. Moreover, it can
be shown (in unpublished work by one of the authors) that any procedure that is not consonant
can be replaced by a consonant one which is at least as good, in the sense that the FWE is
still controlled and there are at least as many rejections as the original procedure. This paper
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provides an explicit construction that yields a strict improvement over existing methods in the
context of testing multiple endpoints with common effect direction.
In order to study the problem formally, Section 2 introduces a maximin sum test under the
normal model and certain restrictions on the parameter space. (Maximin tests are defined in
Lehmann et al., 2005). The normal model, while restrictive, is detailed for two main reasons.
First, even in such a setting, very little optimality theory is known for the multiple testing
problem outside tests that are one-sided; see Lehmann et al. (2005). Second, it is common
for the individual test statistics to be jointly asymptotically normal. The main problem is the
choice of intersection tests when applying closure. Surprisingly, even if each intersection test
has an optimality property, the overall procedure may be inadmissible. Section 3 presents a
consonant maximin sum procedure under similar assumptions, which is shown to be a strict
improvement over the direct application of closure to O’Brien’s tests, as in Lehmacher et al.
(1991). Section 4 applies these concepts to data from the PROactive clinical trial. Section 5
concludes. The Appendix gives some technical details.
2 Rationale for the Sum Test
In this section, we consider a stylized version of the problem. The parametric structure we
now assume is an asymptotic approximation to the more general nonparametric framework.
Think of Xi as denoting a test statistic for the ith hypothesis, and assume (X1, . . . ,Xs) is
multivariate normal with Xi ∼ N(θi, 1) and known covariance matrix Σ. Let θ = (θ1, . . . , θs).
For testing one-sided alternatives in this parametric model, the parameter space is given by
Ω = {θ :
s⋂
i=1
{θi ≥ 0}} . (2)
However, we will also consider two-sided alternatives, but with the restriction that alternatives
(θ1, . . . , θs) are such that all θi have the same sign (possibly negative); that is, we will also
later consider the larger parameter space
Ω′ = {θ :
s⋂
i=1
{θi ≥ 0}}
⋃
{θ :
s⋂
i=1
{θi ≤ 0}} . (3)
For testing Hi : θi = 0 against θi > 0, the test that rejects Hi if Xi > z1−α is UMP level α.
In order to apply closure, we consider tests of the intersection hypothesis θi = 0 for all i.
The general intersection hypothesis HK given in (1) can be handled in the same way by just
considering i ∈ K.
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Proposition 2.1 Consider the multivariate location model with mean vector θ ∈ Ω and known
nonsingular covariance matrix Σ, where the parameter space Ω is given by (2).
(i) For testing θi = 0 for all i against the fixed alternative (θ
′
1, . . . , θ
′
s), the most powerful
test rejects for large values of (θ′)TΣ−1X, where X is a column vector with transpose
XT = (X1, . . . ,Xs) and θ
′ is a column vector with transpose (θ′)T = (θ′1, . . . , θ
′
s). In
particular, no UMP test exists.
(ii) For testing θi = 0 for all i against alternatives (θ
′
1, . . . , θ
′
s) such that all θ
′
i are equal, a
UMP test exists and rejects for large values of the sum of the components of Σ−1X.
(iii) If, in addition, Σ has diagonal elements 1 and off-diagonal elements ρ, then a UMP level α
test exists and rejects the hypothesis that all θi = 0 when
∑
iXi > z1−α[s+ s(s− 1)ρ]
1/2.
Thus, rejecting the intersection hypothesis for large values of the sum
∑
iXi is UMP, but
only for a restricted alternative parameter space, and under a strong assumption on Σ. We
now obtain a maximin result that applies to a much larger alternative parameter space.
Proposition 2.2 Assume Σ has diagonal elements 1 and off-diagonal elements ρ. Consider
testing H0 : θ = (0, 0, . . . , 0) against θ ∈ ω1(ǫ), where
ω1(ǫ) = {θ :
⋂
i
{θi ≥ ǫ}} . (4)
Then, the test that rejects when
∑
iXi > z1−α[s+s(s−1)ρ]
1/2 is maximin; that is, it maximizes
inf{θ ∈ ω1(ǫ) : prθ{reject H0}}.
Remark 2.1 The covariance structure of Proposition 2.2, known as “compound symmetry”,
is a tractable correlation model that is used in a number of practical situations, for example,
repeated measures ANOVA. Unfortunately, if Σ has a different structure, the less tractable
linear combination 1′Σ−1X is maximin. Note the similarity of this test statistic, derived here
by testing and maximizing power, to O’Brien’s (1984, p. 1082) best linear unbiased estimate
of the common mean of possibly correlated random variables.
Finally, for two-sided alternatives with parameter space Ω′ given in (3), an analogous
maximin result holds for the test that rejects for large values of |
∑
Xi|.
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3 Optimal Consonant Tests
Formally, consonant methods satisfy that, if the intersection hypothesis HK defined in (1) is
rejected, then some Hi with i ∈ K is rejected. We concentrate now on how to choose consonant
tests of an intersection hypothesis. What follows is an example of a dissonant test.
Example 3.1 (One-sided normal means) Recall the setup in Section 2 and Proposition 2.2.
If α = 0.05, ρ = 0 and (X1,X2) = (1.4, 1.4), then no Hi can be rejected by closure, even though
H{1,2} is rejected because the sum test rejects if X1 +X2 > 2.326; see Figure 1.
This procedure can be improved if the goal is to make correct decisions about H1 and H2.
To appreciate why, there are points in the rejection region for testing the intersection hypothesis
H{1,2} that do not allow for rejection of either H1 or H2. By removing such points from the
rejection region when testing H{1,2}, we can instead include other points in the rejection region
that satisfy the constraint that the overall rule be consonant, while still maintaining error
control. To achieve that for our overall test of H{1,2}, we restrict attention to tests that have
a rejection region in the plane which lies entirely in {(X1,X2) : max(X1,X2) > z1−α}. Any
intersection test satisfying this constraint will result in a consonant procedure when applying
the closure method.
To see a concrete way to improve upon the above procedure, consider a rejection region Sα
for H{1,2} of the form:
Sα = {(X1,X2) : X1 +X2 > s(1− α), max(Xi) > z1−α} , (5)
where the constant s(1 − α) is determined so that under (θ1, θ2) = (0, 0), the region Sα has
probability α. The rejection region has been obtained from Proposition 2.2 by removing
points that do not support consonance and including points that do. The chance of rejecting
any false individual null hypothesis now increases when applying the closure method. Indeed,
s(1 − α) < 21/2z1−α. For an illustration, see Figure 1. It follows that, for any i = 1, 2, with
θi > 0,
prθ1,θ2{reject Hi using Proposition 2.2} < prθ1,θ2{reject Hi using Sα} ,
That is, the new consonant procedure has uniformly greater power at detecting a false null
hypothesis Hi than the dissonant procedure using the sum statistic for the intersection test.
Similarly, if both nulls are false, the new procedure has a uniformly greater chance of detecting
both hypotheses as false or at least one false hypothesis. In summary, imposing consonance
makes interpretation easier and provides better discriminating ability.
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Thus, applying closure based on intersection tests which each have an optimality property
need not result in an overall optimal procedure for the multiple testing problem. We now
pursue the construction of an optimal choice of the intersection test, which will justify the use
of (5). The following is a modest generalization of the Neyman-Pearson Lemma, where we now
impose the added (consonance) constraint that the rejection region be restricted to a region R
of the sample space.
Lemma 3.1 Suppose P0 and P1 are two probability distributions with densities p0 and p1 with
respect to a dominating measure. Restrict attention to tests φ = φ(X) that are level α, that
is, E0[φ(X)] ≤ α, and such that φ(X) = 0 if X ∈ A, for some fixed region A in the sample
space. Let R = Ac be the complement of A. Among such tests, a test that maximizes the power
against P1 is given by
φ(x) =


1 if L(x) > C and x ∈ R
γ if L(x) = C and x ∈ R
0 if L(x) < 0 or x ∈ A,
(6)
where L(x) = p1(x)/p0(x) and C and γ are chosen to meet the level constraint.
Next, we construct a maximin test by generalizing Theorem 8.1.1 in Lehmann and Romano
(2005), except now we have the added constraint that the rejection region must lie in some fixed
set R. Denote by ω the null hypothesis parameter space and by ω′ the alternative hypothesis
parameter space over which it is desired to maximize the minimum power. The goal is to
determine the test that maximizes infθ∈ω′ Eθ[φ(X)] subject to supθ∈ω Eθ[φ(X)] ≤ α and to the
constraint that the rejection region must lie entirely in a fixed subset R. Let {Pθ, θ ∈ ω ∪ ω
′} be
a family of probability distributions over a sample space (X ,A) with densities pθ = dPθ/dµ with
respect to a σ-finite measure µ, and suppose that the densities pθ(x) considered as functions
of the two variables (x, θ) are measurable (A × B) and (A × B′), where B and B′ are given
σ-fields over ω and ω′.
Theorem 3.1 For any distributions Λ and Λ′ over B and B′, for testing
h(x) =
∫
ω
pθ(x) dΛ(θ)
against
h′(x) =
∫
ω′
pθ(x) dΛ
′(θ) ,
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let ϕΛ,Λ′ be the most powerful among level α tests φ that also satisfy φ(x) = 0 if x ∈ R
c. Also,
let βΛ,Λ′, be its power against the alternative h
′. If Λ and Λ′ satisfy
sup
ω
EθϕΛ,Λ′(X) ≤ α,
(7)
inf
ω′
EθϕΛ,Λ′(X) = βΛ,Λ′ ,
Then, ϕΛ,Λ′ maximizes infω′ Eθϕ(X) among all level-α tests φ(·) of the hypothesis H : θ ∈ ω
which also satisfy φ(x) = 0 if x ∈ Rc, and it is the unique test with this property if it is the
unique most powerful level-α test among tests that accept on Rc for testing h against h′.
Example 3.2 (Continuation of Example 3.1) Recall that (X1,X2) is bivariate normal
with unit variances, E(Xi) = θi, and known correlation ρ. The problem is to test the null
hypotheses Hi : θi = 0 against the one-sided alternatives θi > 0. Theorem 3.1 implies the
following.
Proposition 3.1 Consider the above multiple testing problem. Apply the closure method using
the test that rejects Hi if Xi > z1−α. The test of H{1,2} which maximizes
inf
ω1(ǫ)
prθ1,θ2{reject at least one Hi}
among procedures controlling the FWE is given by (5), where ω1(ǫ) is given by (4).
Remark 3.1 (Test based on the maximum test statistic) In the above multiple testing
problem, the test based on the maximum test statistic works as follows. Denote the ordered
test statistics by T(1) ≤ T(2) with corresponding hypotheses H(1) and H(2). Reject H(2) if
T(2) > q(1− α), where the critical value q(1− α) depends on ρ and satisfies
pr0,0{max(X1,X2) > q(1− α)} = α .
In case H(2) is not rejected, stop. Otherwise, further reject H(1) if T(1) > z1−α.
Example 3.3 (Application to Restricted Two-sided Testing) Consider the setup of Sec-
tion 2, except now we consider the two-sided case. The full parameter space is given by (3) and
Hi specifies θi = 0. Here, (X1,X2) is bivariate normal with unit variances, E(Xi) = θi, and
known correlation ρ. We now determine the consonant, maximin, level α test against ω′1(ǫ)
defined by
ω′1(ǫ) = {θ : θi ≥ ǫ , i = 1, 2}
⋃
{θ : θi ≤ −ǫ , i = 1, 2} . (8)
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Proposition 3.2 Consider the above multiple testing problem. Apply the closure method using
the test that rejects Hi if |Xi| > z1−α
2
. The test of H{1,2} which maximizes
inf
ω′
1
(ǫ)
prθ1,θ2{reject at least one Hi}
among procedures controlling the FWE is given by
{(X1,X2) : |X1 +X2| > r(1− α), max(|Xi|) > z1−α
2
} , (9)
where r(1− α) is determined so that the region has probability α under (θ1, θ2) = (0, 0).
Again, the optimal region takes the same form as the one without restricting to consonant
tests, but just adds the necessary restriction on the rejection region. For an illustration, see
Figure 2. Table 1 shows the critical values r(0.90), r(0.95) and r(0.99) as functions of ρ.
We note that, by symmetry, s(1 − α) = r(1 − 2α), so some one-sided critical values can
also be derived from the table. The critical values r(1 − α) in Table 1 were obtained by
simulation. To see how, fix α. Draw B random samples from the bivariate normal distribution
with means 0, unit variances, and correlation ρ. Call the bth such sample (X∗1 (b),X
∗
2 (b)). If
maxi∈{1,2}(|X
∗
i (b)|) > z1−α
2
, let Y (b) = |
∑2
i=1X
∗
i (b)|; otherwise, let Y (b) = 0. Then, r(1− α)
is obtained as the empirical 1− α quantile of the B values Y (1), . . . , Y (B).
Table 2 compares αˆ, the empirical FWE, and βˆ, the empirical prθ1,θ2(reject ≥ 1 false Hi),
of the Holm and stepwise maxT tests to the (standard) Sum and consonant sum (ConS) tests.
Remark 3.1 provides a definition of the stepwise maxT test in this context; the corresponding
critical values q(1 − α) were also obtained by simulation. Each scenario is based on 50,000
simulations from a bivariate normal distribution with mean vector (θ1, θ2), unit variances, and
correlation ρ = 0 and 0.5, with α = 0.025 (one-sided). Note that maxT is more powerful than
Holm for non-zero ρ, and ConS is always more powerful than Sum. As expected, maxT is most
powerful when there is only one non-zero mean, while ConS is most powerful when there are
two equal non-zero means. With two unequal non-zero means, one large and one medium size,
then ConS is more powerful for ρ = 0 while maxT is more powerful for ρ = 0.5. Finally, note
that Sum’s empirical FWE sometimes falls quite short of 0.025 due to its lack of consonance.
Remark 3.2 (Control of Directional Errors) Suppose that, if Hi is rejected by a given
procedure (such as that of Proposition 3.2), then we declare θi > 0 if Xi > 0 or θi < 0 if
Xi < 0. A directional error occurs if it is declared that θi < 0 when in fact θi > 0, or it is
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declared θi > 0 if θi < 0. Control of the FWE (Type 1 errors) and directional errors together
entails showing: for any (θ1, θ2),
prθ1,θ2{reject at least one true Hi OR make even one directional error} ≤ α . (10)
Note that application of the closure method need not result in control of directional errors;
see Shaffer (1980). For some recent entries into the literature on directional errors, see Finner
(1999) and Shaffer (2002). In general, the value on the left side of (10) will be no smaller
than the probability of at least one false rejection, the FWE. Simulations over a wide range of
(θ1, θ2) and ρ support the validity of (10) for our procedure. However, we can only argue that
the procedure based on Proposition 3.2 satisfies (10) if α is replaced by 3α/2. To see why, if
both Hi are true, there is nothing to prove, since (10) is then covered by FWE control. Next,
suppose both Hi are false. If both θi are < 0, then the left side of (10) is
≤ prθ1,θ2{at least one Xi > z1−α
2
},
which by Bonferroni’s inequality is no bigger than
prθ1{X1 > z1−α
2
}+ prθ2{X2 > z1−α
2
} .
But each term is bounded above by the same expression with θi replaced by 0 (since θi < 0),
leading to the upper bound α. A similar argument holds if one θi is positive and the other
negative, or if both are positive. The final case occurs if one Hi is true and the other false.
Assume without loss of generality that θ1 = 0 and θ2 < 0. Then, the event that H1 is rejected
or θ2 is declared positive implies either |X1| > z1−α
2
or X2 > z1−α
2
. By Bonferroni, the
probability of the union of these events under (0, θ2) is bounded above by
pr0,θ2{|X1| > z1−α
2
}+ pr0,θ2{X2 > z1−α
2
}
The first term equals α. The second term is bounded above by the same expression with θ2
replaced by 0, yielding α/2. The sum 3α/2 is the bound.
Remark 3.3 (General s) The previous results generalize to s hypotheses. For example,
consider Example 3.3, but now for general s. Let (X1, . . . ,Xs) be multivariate normal with
known covariance matrix Σ and mean vector (θ1, . . . , θs). The parameter space consists of Ω
′
given by (3). Assume Σ has all off-diagonal elements equal to ρ and diagonal elements equal
to one. The test that rejects for large values of |
∑
Xi| is maximin, but if used for testing the
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intersection hypothesis that all θi = 0, application of the closure method does not result in
a consonant procedure. To see how closure leads to an improved multiple testing procedure,
first test individual hypotheses Hi by rejecting Hi if |Xi| > z1−α
2
. For testing the general
intersection hypothesis HK , which specifies θi = 0 for i ∈ K, consider the following test with
rejection region
Rα,K ≡ {(X1, . . . ,Xs) : |
∑
i∈K
Xi| > r(1− α,K), and at least one Hi, i ∈ K
is rejected when applying closure to the family {Hi, i ∈ K}},
where the critical value r(1− α,K) is determined so that the above region has probability at
most α when θi = 0 for all i. Evidently, the critical values r(1 − α,K) must be determined
inductively, so that in order to determine r(1 − α,K), we first determine r(1 − α,K ′) for all
K ′ ⊂ K. The test HK is maximin among level α tests which satisfy the consonant constraint
that the rejection region Rα,K must lie in
⋃
K ′⊂K Rα,K ′ . Critical values may be approximated
by simulation similar to the case s = 2. Note that r(1 − α,K) does not depend on s and
depends on K only through |K|.
4 Application to the PROactive Clinical Trial
To illustrate the concepts developed here, we use data from PROactive (PROspective pioglitA-
zone Clinical Trial In macroVascular Events), a randomized, double-blind clinical trial designed
to prospectively investigate the effect of an oral glucose-lowering drug on macrovascular out-
comes (Dormandy et al. 2005). The study enrolled 5, 238 patients with type 2 diabetes and
evidence of macrovascular disease from 19 European countries. Patients were randomly as-
signed to either pioglitazone treatment or a placebo and were allowed to remain on whatever
other anti-diabetic medication they were taking at the start of the study—except for other
agents in pioglitazone’s class—as well as specific cardiovascular and lipid-altering medications.
The PROactive study aimed to achieve significance in a primary composite endpoint, the
time to first occurrence of any of seven events: death, non-fatal MI (myocardial infarction,
including silent MI), stroke, major leg amputation, acute coronary syndrome (ACS), cardiac
intervention—including coronary artery bypass graft (CABG) or percutaneous coronary inter-
vention (PCI)—and leg revascularization. A second endpoint was also of interest, and consisted
of a subset of the primary events: time to first occurrence among death, non-fatal MI (exclud-
ing silent MI) and stroke. More information on the PROactive trial can be found in the website
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www.proactive-results.com/index.htm.
Two interim analyses were performed using an alpha spending function, which reduced
the nominal FWE available at the end of the study to 0.044 from the original 0.05. After
completion of the three-year study, the log-rank test (Lachin (2000)) of the primary endpoint
yielded a p-value of 0.095. The log-rank test of the principal secondary endpoint yielded a
corresponding p-value of 0.027. While Dormandy et al. (2005) claimed a significant outcome,
critics such as Freemantle (2005) countered that a secondary endpoint cannot be deemed
significant absent a significant outcome in the primary endpoint, an assertion supported by
Chi (1998) among others. However, if we viewed both endpoints as corresponding to hypotheses
of equal interest, rather than tiered as “primary” and “secondary”—that is, if we consider the
endpoints to be “co-primary”—significance of the second (rather than secondary) endpoint
could be scientifically assessed through a testing strategy that controls the FWE. We note
that at the time of study design the primary endpoint was defined and recognized as clinically
relevant, under the assumption that all vascular beds would be equally affected by the disease
state. However, the clinical relevance of the secondary endpoint was also apparent. Would
the second endpoint have attained significance had the testing methods set forth in this article
been applied?
The closed family of tests for this example consists of the tests of hypotheses H1 and H2 of
the respective co-primary endpoints and the global null hypothesis H{1,2} that neither endpoint
exhibits a treatment effect. Results from tests of H1 and H2 are already available from the
log-rank tests, as outlined above. Thus we proceed to test the intersection hypothesis H{1,2}
by applying the methods of this paper, and note that if our test produces a p-value less than
or equal to 0.044, the second endpoint could have been declared significant—not by ignoring
the multiplicity problem, but by proper control of the FWE.
The now co-primary endpoints are clearly related and highly correlated, sharing the com-
mon components of death, non-fatal MI and stroke. Even before results were published, we
would have expected a treatment effect—if there were one—to be apparent in both endpoints.
If we wish to find a test of H{1,2} that directs power in the direction of our alternative hy-
pothesis of a common effect direction, in the region ω′1(ǫ) of (8), the absolute sum test or its
modified consonant maximin sum test of Proposition 3.2 are the obvious choices.
Since the log-rank test statistics are available, our first inclination might be to sum them.
But in the case of no ties, Cox (1972) derived the log-rank test as an efficient score test in
a proportional hazards (PH) regression model with a single binary covariate for treatment
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group; see Lachin (2000). This equivalence with the PH model, which holds approximately if
there are relatively few ties, allows us instead to sum the studentized parameter estimates in
a simple fit of the WLW marginal model with two endpoints, a relatively simple task in SAS.
Notice that this sum can represent an overall treatment effect, as measured by the PH model,
and corresponds to the sum of the logs of the hazard ratios. Wei et al. (1989) showed that
these parameter estimates, based on the endpoint-specific partial likelihoods, are approximately
normal for large sample sizes.
Let η be the vector of s = 2 parameters in the WLW marginal model. From the robust
covariance matrix (Liang and Zeger (1986)) output by SAS, we estimate the standard errors as
well as the correlation between the parameter estimates, ρˆ = 0.74. Studentizing the parameter
estimates as Xi = ηˆi/SE(ηˆi) yields X1 = −1.667 and X2 = −2.202. We test the intersection
hypothesis H{1,2} : η1 = η2 = 0 by forming the test statistic, as in Proposition 2.2, (X1 +
X2)/(2 + 2ρˆ)
1/2 = −2.073. The probability of a larger absolute value under the standard
normal is 0.038. Since it is below 0.044, the available α, we reject the intersection hypothesis
and, by the closure principle, claim that the second endpoint indeed had a significant treatment
effect, even after accounting for multiple testing.
But what result would be obtained from the PROactive data if we applied the consonant
maximin sum test of Proposition 3.2? To calculate the critical value for this test we drew
B = 50, 000 random samples from the bivariate normal (0, 0, 1, 1) distribution with correlation
0.74, the observed correlation between the WLW parameter estimates. Following the approach
of Example 3.3, we generated the approximate quantile r(1 − 0.044) = 3.700. (A linearly
interpolated value from Table 1, at ρ = 0.74, is roughly 3.768, somewhat far from the value
generated through simulation, as these critical values are quite nonlinear in the inputs, espe-
cially in the level.) The sum of the studentized parameter estimates has absolute value 3.869,
corresponding to a p-value of 0.036. Hence, we can again reject H{1,2} and by consonance claim
significance of the second endpoint.
5 Conclusion
Clinical research and other investigations may record several endpoints which each measure the
effectiveness of a treatment, and which may be correlated or mechanistically related. In order
to provide powerful hypothesis tests in such problems, O’Brien (1984) proposed an overall test
based on the sum of the endpoint measures. We established a theoretical grounding to the
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sum test, complementing its intuitive appeal. Lehmacher et al. (1991) considered the sum test
as an engine for testing within a closed test framework. The straightforward use of the sum
test is not consonant in this situation, but we defined a new class of rejection regions in which
intersection tests based on sum statistics do achieve consonance. The new, consonant test has
a maximin property among tests that control the FWE. We applied the new procedures to
PROactive data and showed that, had the trial’s hypothesis testing been designed as a closed
test, with the two endpoints as co-primary, both the simple sum test and the new consonant
sum test would have established a general treatment effect and identified one of the endpoints
as statistically significant.
A Proofs
Proof of Proposition 2.1. The proof is an application of the Neyman-Pearson Lemma.
Proof of Proposition 2.2. The least favorable distribution concentrates on the single point
(ǫ, . . . , ǫ). Maximinity results because the resulting test against this fixed alternative has an
increasing power function in each of the components θi, and therefore the power is minimized
over ω1(ǫ) at (ǫ, . . . , ǫ).
Proof of Lemma 3.1 The goal is to maximize EP1[φ(X)I{X ∈ R}] subject to EP0[φ(X)I{X ∈
R}] ≤ α. Let Qi denote the conditional distribution of X given X ∈ R when X ∼ Pi. Also,
let βi = Pi{R}. Then, equivalently, the problem is to maximize β1
−1EQ1[φ(X)] subject to
EQ0[φ(X)] ≤ α/β0, or equivalently maximize EQ1[φ(X)] subject to EQ0[φ(X)] ≤ α
′ = α/β0.
By the Neyman Pearson Lemma, the optimal test rejects for large values of the likelihood ratio
dQ1(X)/dQ0(X), which is a constant multiple of L(X).
Proof of Theorem 3.1. If ϕ∗ is any other level-α test of H satisfying ϕ∗(X) = 0 if X ∈ Rc,
it is also of level α for testing the simple hypothesis that the density of X is h; therefore, the
power of ϕ∗ against h′ cannot exceed βΛ,Λ′ . It follows that
inf
ω′
Eθϕ
∗(X) ≤
∫
ω′
Eθϕ
∗(X) dΛ′(θ) ≤ βΛ,Λ′ = inf
ω′
EθϕΛΛ′(X),
and the second inequality is strict if ϕΛΛ′ is unique.
Proof of Proposition 3.1: Consider any other method based on closure which rejects Hi
if Xi > z1−α and controls the FWE. Let S
′ denote its rejection region for H{1,2}. Furthermore,
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let S′′ = S′ ∩ R, where R = {(X1,X2) : min(Xi) > z1−α}. Then, using S
′ or S′′ results in
the same outcomes for the individual tests of Hi as far as the closure method is concerned. In
particular, the probability of rejecting at least one Hi using S
′ (combined with closure) is the
same as the probability of rejecting at least one Hi using S
′′. But for S′′ ⊂ R, the procedure is
now consonant and the probability of rejecting at least one Hi is the same as the probability
of just rejecting the intersection hypothesis based on S′′. So, the optimal choice for S′′ is
given by Theorem 3.1. To now apply the theorem, take Λ′ to concentrate on (ǫ, ǫ) and apply
Lemma 3.1. The resulting test with rejection region Sα is then easily seen to be the consonant
sum test given by (5).
Proof of Proposition 3.2: The proof is analogous to the proof of Proposition 3.1, except
that Λ′ puts equal mass at (ǫ, ǫ) and (−ǫ,−ǫ).
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ρ r(0.90) r(0.95) r(0.99) ρ r(0.90) r(0.95) r(0.99)
0.0 1.982 2.290 2.878
−0.1 1.804 2.075 2.596 0.1 2.152 2.498 3.153
−0.2 1.617 1.853 2.313 0.2 2.314 2.700 3.421
−0.3 1.423 1.622 2.031 0.3 2.467 2.892 3.687
−0.4 1.228 1.392 1.743 0.4 2.611 3.071 3.943
−0.5 1.024 1.160 1.452 0.5 2.746 3.240 4.194
−0.6 0.819 0.930 1.161 0.6 2.872 3.401 4.427
−0.7 0.614 0.696 0.866 0.7 2.988 3.548 4.634
−0.8 0.409 0.465 0.581 0.8 3.095 3.683 4.827
−0.9 0.205 0.231 0.291 0.9 3.197 3.807 5.003
−1.0 0.000 0.000 0.000 1.0 3.290 3.920 5.152
Table 1: The critical values r(0.90), r(0.95), and r(0.99) as functions of the correlation ρ. These
values were obtained by B = 106 Monte Carlo simulations.
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ρ = 0 (θ1, θ2) Holm maxT Sum ConS Holm maxT Sum ConS
αˆ (0,0) 0.0249 0.0251 0.0159 0.0242 βˆ 0 0 0 0
(3,0) 0.0215 0.0215 0.0241 0.0242 0.778 0.779 0.549 0.660
(3,1.5) 0 0 0 0 0.829 0.829 0.852 0.881
(3,3) 0 0 0 0 0.951 0.951 0.976 0.978
ρ = 0.5 (θ1, θ2) Holm maxT Sum ConS Holm maxT Sum ConS
αˆ (0,0) 0.0235 0.0250 0.0218 0.0246 βˆ 0 0 0 0
(3,0) 0.0237 0.0237 0.0240 0.0240 0.778 0.787 0.411 0.446
(3,1.5) 0 0 0 0 0.793 0.801 0.735 0.758
(3,3) 0 0 0 0 0.898 0.904 0.925 0.931
Table 2: Comparison of empirical FWE, denoted by αˆ, and empirical power, denoted by βˆ,
attained by different methods as functions of the correlation ρ and the true means (θ1, θ2).
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Figure 1: The rejection regions for the test of Proposition 2.2 and its improvement of Proposition 3.1
with nominal level α = 0.05 when the correlation is ρ = 0. The test of Proposition 2.2 rejects for points
to the right and above the dashed line with intercept 2.326 and slope −1. The improved test of Proposi-
tion 3.1 rejects for points to the right and above the solid curve defined by (5) with s(0.95) = 1.985 and
z1−α = 1.645. For example, the point (1.4, 1.4) leads to a rejection by the test of Proposition 2.2 but
not by the improved test. On the other hand, the point (1.9, 0.25) leads to a rejection by the improved
test of Proposition 3.1 but not by the test of Proposition 2.2.The region which leads to at least one
individual rejection by the improved test but not by the standard test is shaded.
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Figure 2: The rejection regions for the test of the two-sided version of Proposition 2.2 based on the
absolute sum, and its improvement of Proposition 3.2 with nominal level α = 0.05 when the correlation
is ρ = 0. The absolute sum test rejects for points outside the dashed band. The improved test rejects
for points outside the solid ‘band’. For example, the point (1.6, 1.6) leads to a rejection by the absolute
sum test (though no individual Hi are rejected), but not by the improved test of Proposition 3.2. On
the other hand, the point (2.3, 0.2) leads to a rejection by the improved test but not by the absolute
sum test. The region which leads to at least one individual rejection by the improved test but not by
the absolute test is shaded.
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